Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients

Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity

(2019) Michela Capello et al.   Nature Communications

Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers

(2019) Laura Follia et al.   Frontiers in Oncology

Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners

(2018) Paola Cappello et al.   Cancers

Haptoglobin phenotype is a critical factor in the use of fucosylated haptoglobin for pancreatic cancer diagnosis

(2018) Koichi Morishita et al.   CLINICA CHIMICA ACTA

S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes

(2018) Taoufik Nedjadi et al.   BMC CANCER

Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability

(2016) Xiangchun Li et al.   CANCER RESEARCH

Application of glycoscience to the early detection of pancreatic cancer

(2016) Eiji Miyoshi et al.   CANCER SCIENCE

Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

(2016) Maxim V. Kuleshov et al.   NUCLEIC ACIDS RESEARCH

Discovery and Validation of Biomarkers That Distinguish Mucinous and Nonmucinous Pancreatic Cysts

(2015) J. Park et al.   CANCER RESEARCH

Immunity, inflammation, and cancer: an eternal fight between good and evil

(2015) Shabnam Shalapour et al.   JOURNAL OF CLINICAL INVESTIGATION

CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma

(2015) Dag Nymoen et al.   Molecular Cancer

Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity

(2015) Yaron Carmi et al.   NATURE

Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1α signaling

(2015) Bingqing Huang et al.   Oncotarget

Next maSigPro: updating maSigPro bioconductor package for RNA-seq time series

(2014) M. J. Nueda et al.   BIOINFORMATICS

Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1

(2014) Daniela Basso et al.   Cell Communication and Signaling

Adiponectin Inhibits Murine Pancreatic Cancer Growth

(2014) Motohiko Kato et al.   DIGESTIVE DISEASES AND SCIENCES

Multifaceted roles of Adiponectin in cancer

(2013) Lionel Hebbard et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer

(2013) L Bracci et al.   CELL DEATH AND DIFFERENTIATION

Vaccination With ENO1 DNA Prolongs Survival of Genetically Engineered Mice With Pancreatic Cancer

(2013) Paola Cappello et al.   GASTROENTEROLOGY

Genetic Alterations Associated With Progression From Pancreatic Intraepithelial Neoplasia to Invasive Pancreatic Tumor

(2013) Stephen J. Murphy et al.   GASTROENTEROLOGY

Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura

(2013) S. Ferrari et al.   HAEMATOLOGICA

Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma

(2013) Jiong Chen et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models

(2013) Michela Capello et al.   Journal of Hematology & Oncology

Identification of Autoantigens in Body Fluids by Combining Pull-Downs and Organic Precipitations of Intact Immune Complexes with Quantitative Label-Free Mass Spectrometry

(2013) Juliane Merl et al.   JOURNAL OF PROTEOME RESEARCH

Vaccines for Pancreatic Cancer

(2012) Kevin C. Soares et al.   CANCER JOURNAL

Molecular Profiling of Pancreatic Neuroendocrine Tumors in Sporadic and Von Hippel-Lindau Patients

(2012) D. Speisky et al.   CLINICAL CANCER RESEARCH

A Prospective Study of Plasma Adiponectin and Pancreatic Cancer Risk in Five US Cohorts

(2012) Ying Bao et al.   JNCI-Journal of the National Cancer Institute

The GCTM-5 Epitope Associated with the Mucin-Like Glycoprotein FCGBP Marks Progenitor Cells in Tissues of Endodermal Origin

(2012) Lincon A. Stamp et al.   STEM CELLS

Lung Cancer Serum Biomarker Discovery Using Label-Free Liquid Chromatography-Tandem Mass Spectrometry

(2011) Xuemei Zeng et al.   Journal of Thoracic Oncology

Transthyretin, identified by proteomics, is overabundant in pancreatic juice from pancreatic carcinoma and originates from pancreatic islets

(2010) Shunli Lv et al.   DIAGNOSTIC CYTOPATHOLOGY

Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer

(2010) Barbara Tomaino et al.   JOURNAL OF PROTEOME RESEARCH

An integrated humoral and cellular response is elicited in pancreatic cancer by α-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen

(2009) Paola Cappello et al.   INTERNATIONAL JOURNAL OF CANCER

Serum leptin, but not adiponectin and receptor for advanced glycation end products, is able to distinguish autoimmune pancreatitis from both chronic pancreatitis and pancreatic neoplasms

(2009) Raffaele Pezzilli et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings

(2009) Hiroyuki Katayama et al.   Genome Medicine

Prediagnostic Adiponectin Concentrations and Pancreatic Cancer Risk in Male Smokers

(2008) R. Z. Stolzenberg-Solomon et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case–control study

(2008) Maria Dalamaga et al.   CANCER CAUSES & CONTROL